Evaluation of Anti-Platelet Aggregation Effect of Some Allium Species

被引:1
|
作者
Lorigooini, Zahra [1 ]
Ayatollahi, Seyed Abdolmajid [1 ,2 ]
Amidi, Salimeh [1 ]
Kobarfard, Farzad [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacognosy, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran
来源
关键词
Allium species; Alliaceae; Cardiovascular disease; Anti-platelet; Platelet aggregation; ONION; EXTRACT; PLATELETS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Epidemiologic studies show that the cardiovascular diseases are associated with multiple factors such as raised serum total cholesterol, increased LDL, increased platelet aggregation, hypertension and smoking. In-vitro studies have confirmed the ability of some plants of Allium species to reduce these parameters. Therefore, we evaluated anti-platelet aggregation effect of some Allium species (Allium ampeloprasum, A. hirtifolium, A. haemanthoides, A. vavillovi, A. atroviolaceum, A. jesdianum, A. shelkovnikovii) using arachidonic acid (AA) and adenosine diphosphate (ADP) as platelet aggregation inducers. The screening results for methanolic extract of Allium species showed that the maximum effect of anti-platelet aggregation was related to A. atroviolaceum. This extract inhibited the in-vitro platelet aggregation induced by AA and ADP with IC50 values of 0.4881 (0.4826-0.4937) mg/ml and 0.4945 (0.4137-0.5911) mg/ml respectively. These results support the hypothesis that the dietary intake of Allium could be beneficial for prevention of cardiovascular diseases.
引用
收藏
页码:1225 / 1231
页数:7
相关论文
共 50 条
  • [11] Anti-platelet aggregation constituents from Gynura elliptica
    Lin, WY
    Teng, CM
    Tsai, IL
    Chen, IS
    PHYTOCHEMISTRY, 2000, 53 (08) : 833 - 836
  • [12] Anti-platelet aggregation activity observed in Honkaku shochu
    Sumi, H.
    Fujii, S.
    Tokudome, S.
    Yoshida, E.
    Yatagai, C.
    Naito, S.
    Maruyama, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1190 - 1190
  • [13] TREATMENT VALVULAR PROSTHESES AND ANTI-PLATELET AGGREGATION TREATMENT
    ISMAIL, MB
    GHARIANI, M
    JAIS, JM
    NOUVELLE PRESSE MEDICALE, 1975, 4 (10): : 746 - 746
  • [14] STROKE THERAPY - STATUS OF ANTI-PLATELET AGGREGATION DRUGS
    YATSU, FM
    NEUROLOGY, 1977, 27 (06) : 503 - 504
  • [15] THE ANTI-PLATELET EFFECT OF NICERITROL IN PATIENTS WITH ARTERIOSCLEROSIS AND THE RELATIONSHIP OF THE LIPID-LOWERING EFFECT TO THE ANTI-PLATELET EFFECT
    NAGAKAWA, Y
    ORIMO, H
    HARASAWA, M
    THROMBOSIS RESEARCH, 1985, 40 (04) : 543 - 553
  • [16] Synthesis and biological evaluation of n-butylphthalide derivatives as anti-platelet aggregation agents
    Chen, Meihui
    Liu, Qi
    Tan, Min
    Wen, Shijun
    Pi, Rongbiao
    Lin, Dingkun
    NATURAL PRODUCT RESEARCH, 2016, 30 (23) : 2716 - 2719
  • [17] ANTI-PLATELET DRUGS - SOME MECHANISMS AND INDICATIONS
    WARREN, DE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1979, 13 (02): : 78 - 83
  • [18] Three new flavonoid glycosides from the aerial parts of Allium sativum L. and their anti-platelet aggregation assessment
    Hu, Bin
    Hu, Haibo
    Pu, Chuan
    Wei, Zheng
    Wang, Qiuhong
    Kuang, Haixue
    NATURAL PRODUCT RESEARCH, 2022, 36 (23) : 5940 - 5949
  • [19] EFFECT OF ANTI-PLATELET TUBULIN ANTIBODY ON PLATELET FUNCTIONS
    IKEDA, Y
    FURIHATA, K
    IMAI, M
    SUGIURA, K
    TOYAMA, K
    YAMAMOTO, M
    WATANABE, K
    ANDO, Y
    ACTA HAEMATOLOGICA JAPONICA, 1981, 44 (03): : 652 - 657
  • [20] Anti-platelet aggregation mechanisms of quercetin fatty acid ester
    Duan, Yu, 1600, Journal of Chemical and Pharmaceutical Research, 3/668 Malviya Nagar, Jaipur, Rajasthan, India (06):